Tempest Announces Closing of Strategic Acquisition of Dual-Targeting CAR-T Assets Life Science Investing
Acadia Pharmaceuticals to Announce Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026 Life Science Investing
Relay Therapeutics to Participate in Guggenheim Emerging Outlook: Biotech Summit 2026 Life Science Investing
RenovoRx Announces Clinical Data Supporting the TAMP Therapy Platform will be Presented at the SIO 2026 Annual Scientific Meeting Life Science Investing
Nature Medicine Publishes Results from the Pivotal DEVOTE Study of High-Dose Regimen of Nusinersen in Spinal Muscular Atrophy Life Science Investing
Sionna Therapeutics to Present at the Guggenheim Securities Emerging Outlook: Biotech Summit 2026 Life Science Investing
Maze Therapeutics to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026 Life Science Investing
C4 Therapeutics to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026 Life Science Investing
BriaCell Receives Positive Recommendation from Data Safety Monitoring Board for Phase 3 Study in Metastatic Breast Cancer
